<DOC>
	<DOC>NCT00999141</DOC>
	<brief_summary>The purpose of the study is to compare the safety and efficacy of FS VH S/D 4 s-apr versus standard of care in adhering tissue and improving wound healing in subjects undergoing facelift.</brief_summary>
	<brief_title>Efficacy and Safety of FS VH S/D 4 S-apr for Flap Adherence in Rhytidectomy</brief_title>
	<detailed_description />
	<criteria>Male or female subject is 18 to 75 years of age at the time of screening Subject is planned for facial rhytidectomy Subject has read, understood and signed the written informed consent Subject is healthy, as determined by the investigator using standard preoperative assessments to include laboratory tests and electrocardiograms Subject is of childbearing potential, presents with a negative serum pregnancy test, and agrees to employ adequate birth control measures for the duration of the study Subject is willing and able to comply with the requirements of the protocol Subject is indicated for an abbreviated or modified facelift procedure such as deep plane procedures, minimal undermining procedures, thread lifts, and minimal access cranial suspension Subject is indicated for concurrent facial surgeries during the operation (eg forehead plasty,blepharoplasty, rhinoplasty, buccal fat removal, any filler injections including fat injections, lip augmentation, skin resurfacing procedures etc.) Subject is indicated for additional procedures to the body during the same operation (eg liposuction, mastoplasty etc.) Subject has undergone a prior rhytidectomy surgery Subject is an active smoker, as assessed by the investigator Subject has a known (documented) bleeding or coagulation disorder Subject is being treated with anticoagulants or with Aspirin (that was not discontinued 7 days prior to surgery) Subject has a vascular disorder, cardiovascular disease, and/or uncontrolled hypertension Subject has diabetes mellitus with glycosylated hemoglobin (HbA1c) &gt; 7 Subject is receiving active treatment for a malignancy Subject has a connective tissue disorder Subject has an active or chronic skin disorder Subject has history of Bell's palsy Subject has a documented history of pathologically or pharmacologically induced immune deficiency Subject has received chronic treatment with immunosuppressive drugs, systemic corticosteroids, or other chronic treatments within 30 days prior to the surgery Subject has a known sensitivity to components of FS VH S/D 4 sapr Subject has a known psychiatric disorder (eg, obsessive compulsive disorder, anxiety, eating disorders, etc.) Subject has documented healing complications following previous surgeries (eg, hypertrophic scarring) Subject is pregnant or lactating at the time of enrollment Subject has participated in another clinical study involving an investigational product/device within 30 days prior to enrollment or is scheduled to participate in another clinical study involving an investigational product/device during the course of this study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>October 2012</verification_date>
</DOC>